nodes	percent_of_prediction	percent_of_DWPC	metapath
Methocarbamol—CA1—nerve—acquired immunodeficiency syndrome	0.0368	0.239	CbGeAlD
Methocarbamol—CA1—blood plasma—acquired immunodeficiency syndrome	0.0278	0.181	CbGeAlD
Methocarbamol—CA1—lymphoid tissue—acquired immunodeficiency syndrome	0.0108	0.0705	CbGeAlD
Methocarbamol—CA1—digestive system—acquired immunodeficiency syndrome	0.0107	0.0696	CbGeAlD
Methocarbamol—CA1—blood—acquired immunodeficiency syndrome	0.0102	0.0663	CbGeAlD
Methocarbamol—CA1—bone marrow—acquired immunodeficiency syndrome	0.00986	0.0642	CbGeAlD
Methocarbamol—CA1—spinal cord—acquired immunodeficiency syndrome	0.00982	0.0639	CbGeAlD
Methocarbamol—CA1—lung—acquired immunodeficiency syndrome	0.00894	0.0582	CbGeAlD
Methocarbamol—CA1—nervous system—acquired immunodeficiency syndrome	0.00827	0.0539	CbGeAlD
Methocarbamol—CA1—central nervous system—acquired immunodeficiency syndrome	0.00797	0.0518	CbGeAlD
Methocarbamol—CA1—brain—acquired immunodeficiency syndrome	0.00632	0.0412	CbGeAlD
Methocarbamol—CA1—lymph node—acquired immunodeficiency syndrome	0.00611	0.0398	CbGeAlD
Methocarbamol—Anaphylactic shock—Nevirapine—acquired immunodeficiency syndrome	0.00348	0.00412	CcSEcCtD
Methocarbamol—Jaundice—Ritonavir—acquired immunodeficiency syndrome	0.00347	0.0041	CcSEcCtD
Methocarbamol—Conjunctivitis—Ritonavir—acquired immunodeficiency syndrome	0.00346	0.00409	CcSEcCtD
Methocarbamol—Dyspepsia—Didanosine—acquired immunodeficiency syndrome	0.00341	0.00403	CcSEcCtD
Methocarbamol—Flushing—Efavirenz—acquired immunodeficiency syndrome	0.00336	0.00396	CcSEcCtD
Methocarbamol—Jaundice—Saquinavir—acquired immunodeficiency syndrome	0.00334	0.00395	CcSEcCtD
Methocarbamol—Conjunctivitis—Saquinavir—acquired immunodeficiency syndrome	0.00333	0.00394	CcSEcCtD
Methocarbamol—Anaphylactic shock—Abacavir—acquired immunodeficiency syndrome	0.00331	0.00391	CcSEcCtD
Methocarbamol—Pain—Didanosine—acquired immunodeficiency syndrome	0.00331	0.00391	CcSEcCtD
Methocarbamol—Angioedema—Zidovudine—acquired immunodeficiency syndrome	0.00327	0.00387	CcSEcCtD
Methocarbamol—Dysgeusia—Indinavir—acquired immunodeficiency syndrome	0.00326	0.00385	CcSEcCtD
Methocarbamol—Vertigo—Zidovudine—acquired immunodeficiency syndrome	0.00322	0.0038	CcSEcCtD
Methocarbamol—Syncope—Zidovudine—acquired immunodeficiency syndrome	0.00321	0.00379	CcSEcCtD
Methocarbamol—Leukopenia—Zidovudine—acquired immunodeficiency syndrome	0.00321	0.00379	CcSEcCtD
Methocarbamol—Jaundice—Lamivudine—acquired immunodeficiency syndrome	0.00319	0.00377	CcSEcCtD
Methocarbamol—Loss of consciousness—Zidovudine—acquired immunodeficiency syndrome	0.00315	0.00372	CcSEcCtD
Methocarbamol—Vision blurred—Indinavir—acquired immunodeficiency syndrome	0.00314	0.00371	CcSEcCtD
Methocarbamol—Convulsion—Zidovudine—acquired immunodeficiency syndrome	0.0031	0.00367	CcSEcCtD
Methocarbamol—Somnolence—Nevirapine—acquired immunodeficiency syndrome	0.0031	0.00366	CcSEcCtD
Methocarbamol—Hypotension—Abacavir—acquired immunodeficiency syndrome	0.0031	0.00366	CcSEcCtD
Methocarbamol—Dysgeusia—Efavirenz—acquired immunodeficiency syndrome	0.00308	0.00364	CcSEcCtD
Methocarbamol—Body temperature increased—Didanosine—acquired immunodeficiency syndrome	0.00306	0.00362	CcSEcCtD
Methocarbamol—Insomnia—Nelfinavir—acquired immunodeficiency syndrome	0.00305	0.0036	CcSEcCtD
Methocarbamol—Angioedema—Indinavir—acquired immunodeficiency syndrome	0.00304	0.0036	CcSEcCtD
Methocarbamol—Insomnia—Stavudine—acquired immunodeficiency syndrome	0.00304	0.00359	CcSEcCtD
Methocarbamol—Pruritus—Amprenavir—acquired immunodeficiency syndrome	0.00301	0.00355	CcSEcCtD
Methocarbamol—Somnolence—Nelfinavir—acquired immunodeficiency syndrome	0.003	0.00354	CcSEcCtD
Methocarbamol—Insomnia—Abacavir—acquired immunodeficiency syndrome	0.003	0.00354	CcSEcCtD
Methocarbamol—Vertigo—Indinavir—acquired immunodeficiency syndrome	0.00299	0.00354	CcSEcCtD
Methocarbamol—Somnolence—Stavudine—acquired immunodeficiency syndrome	0.00299	0.00353	CcSEcCtD
Methocarbamol—Syncope—Indinavir—acquired immunodeficiency syndrome	0.00299	0.00353	CcSEcCtD
Methocarbamol—Pain—Nevirapine—acquired immunodeficiency syndrome	0.00298	0.00352	CcSEcCtD
Methocarbamol—Dyspepsia—Nelfinavir—acquired immunodeficiency syndrome	0.00297	0.00351	CcSEcCtD
Methocarbamol—Flushing—Ritonavir—acquired immunodeficiency syndrome	0.00297	0.00351	CcSEcCtD
Methocarbamol—Vision blurred—Efavirenz—acquired immunodeficiency syndrome	0.00297	0.0035	CcSEcCtD
Methocarbamol—Dyspepsia—Stavudine—acquired immunodeficiency syndrome	0.00296	0.0035	CcSEcCtD
Methocarbamol—Dysgeusia—Delavirdine—acquired immunodeficiency syndrome	0.00295	0.00348	CcSEcCtD
Methocarbamol—Confusional state—Zidovudine—acquired immunodeficiency syndrome	0.00295	0.00348	CcSEcCtD
Methocarbamol—Loss of consciousness—Indinavir—acquired immunodeficiency syndrome	0.00293	0.00346	CcSEcCtD
Methocarbamol—Anaphylactic shock—Zidovudine—acquired immunodeficiency syndrome	0.00292	0.00345	CcSEcCtD
Methocarbamol—Pain—Nelfinavir—acquired immunodeficiency syndrome	0.00288	0.00341	CcSEcCtD
Methocarbamol—Pain—Stavudine—acquired immunodeficiency syndrome	0.00288	0.0034	CcSEcCtD
Methocarbamol—Shock—Zidovudine—acquired immunodeficiency syndrome	0.00288	0.0034	CcSEcCtD
Methocarbamol—Angioedema—Efavirenz—acquired immunodeficiency syndrome	0.00288	0.0034	CcSEcCtD
Methocarbamol—Feeling abnormal—Nevirapine—acquired immunodeficiency syndrome	0.00287	0.00339	CcSEcCtD
Methocarbamol—Hypersensitivity—Didanosine—acquired immunodeficiency syndrome	0.00285	0.00337	CcSEcCtD
Methocarbamol—Vision blurred—Delavirdine—acquired immunodeficiency syndrome	0.00284	0.00335	CcSEcCtD
Methocarbamol—Pain—Abacavir—acquired immunodeficiency syndrome	0.00283	0.00335	CcSEcCtD
Methocarbamol—Vertigo—Efavirenz—acquired immunodeficiency syndrome	0.00283	0.00334	CcSEcCtD
Methocarbamol—Syncope—Efavirenz—acquired immunodeficiency syndrome	0.00282	0.00333	CcSEcCtD
Methocarbamol—Feeling abnormal—Nelfinavir—acquired immunodeficiency syndrome	0.00278	0.00328	CcSEcCtD
Methocarbamol—Urticaria—Nevirapine—acquired immunodeficiency syndrome	0.00277	0.00327	CcSEcCtD
Methocarbamol—Loss of consciousness—Efavirenz—acquired immunodeficiency syndrome	0.00277	0.00327	CcSEcCtD
Methocarbamol—Body temperature increased—Nevirapine—acquired immunodeficiency syndrome	0.00275	0.00325	CcSEcCtD
Methocarbamol—Angioedema—Delavirdine—acquired immunodeficiency syndrome	0.00275	0.00325	CcSEcCtD
Methocarbamol—Pruritus—Didanosine—acquired immunodeficiency syndrome	0.00274	0.00324	CcSEcCtD
Methocarbamol—Feeling abnormal—Abacavir—acquired immunodeficiency syndrome	0.00273	0.00323	CcSEcCtD
Methocarbamol—Dysgeusia—Ritonavir—acquired immunodeficiency syndrome	0.00273	0.00322	CcSEcCtD
Methocarbamol—Convulsion—Efavirenz—acquired immunodeficiency syndrome	0.00273	0.00322	CcSEcCtD
Methocarbamol—Anaphylactic shock—Indinavir—acquired immunodeficiency syndrome	0.00272	0.00321	CcSEcCtD
Methocarbamol—Vertigo—Delavirdine—acquired immunodeficiency syndrome	0.00271	0.0032	CcSEcCtD
Methocarbamol—Vomiting—Amprenavir—acquired immunodeficiency syndrome	0.0027	0.00319	CcSEcCtD
Methocarbamol—Syncope—Delavirdine—acquired immunodeficiency syndrome	0.0027	0.00319	CcSEcCtD
Methocarbamol—Leukopenia—Delavirdine—acquired immunodeficiency syndrome	0.0027	0.00318	CcSEcCtD
Methocarbamol—Urticaria—Nelfinavir—acquired immunodeficiency syndrome	0.00268	0.00317	CcSEcCtD
Methocarbamol—Rash—Amprenavir—acquired immunodeficiency syndrome	0.00268	0.00317	CcSEcCtD
Methocarbamol—Dermatitis—Amprenavir—acquired immunodeficiency syndrome	0.00268	0.00316	CcSEcCtD
Methocarbamol—Shock—Indinavir—acquired immunodeficiency syndrome	0.00267	0.00316	CcSEcCtD
Methocarbamol—Urticaria—Stavudine—acquired immunodeficiency syndrome	0.00267	0.00316	CcSEcCtD
Methocarbamol—Body temperature increased—Nelfinavir—acquired immunodeficiency syndrome	0.00267	0.00315	CcSEcCtD
Methocarbamol—Headache—Amprenavir—acquired immunodeficiency syndrome	0.00266	0.00315	CcSEcCtD
Methocarbamol—Body temperature increased—Stavudine—acquired immunodeficiency syndrome	0.00266	0.00314	CcSEcCtD
Methocarbamol—Loss of consciousness—Delavirdine—acquired immunodeficiency syndrome	0.00265	0.00313	CcSEcCtD
Methocarbamol—Insomnia—Zidovudine—acquired immunodeficiency syndrome	0.00264	0.00312	CcSEcCtD
Methocarbamol—Urticaria—Abacavir—acquired immunodeficiency syndrome	0.00263	0.00311	CcSEcCtD
Methocarbamol—Dysgeusia—Saquinavir—acquired immunodeficiency syndrome	0.00262	0.0031	CcSEcCtD
Methocarbamol—Vision blurred—Ritonavir—acquired immunodeficiency syndrome	0.00262	0.0031	CcSEcCtD
Methocarbamol—Body temperature increased—Abacavir—acquired immunodeficiency syndrome	0.00262	0.00309	CcSEcCtD
Methocarbamol—Somnolence—Zidovudine—acquired immunodeficiency syndrome	0.0026	0.00307	CcSEcCtD
Methocarbamol—Confusional state—Efavirenz—acquired immunodeficiency syndrome	0.00259	0.00306	CcSEcCtD
Methocarbamol—Dyspepsia—Zidovudine—acquired immunodeficiency syndrome	0.00257	0.00304	CcSEcCtD
Methocarbamol—Hypersensitivity—Nevirapine—acquired immunodeficiency syndrome	0.00257	0.00303	CcSEcCtD
Methocarbamol—Shock—Efavirenz—acquired immunodeficiency syndrome	0.00253	0.00299	CcSEcCtD
Methocarbamol—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.00252	0.00298	CcSEcCtD
Methocarbamol—Dysgeusia—Lamivudine—acquired immunodeficiency syndrome	0.0025	0.00296	CcSEcCtD
Methocarbamol—Vertigo—Ritonavir—acquired immunodeficiency syndrome	0.0025	0.00296	CcSEcCtD
Methocarbamol—Pain—Zidovudine—acquired immunodeficiency syndrome	0.0025	0.00295	CcSEcCtD
Methocarbamol—Syncope—Ritonavir—acquired immunodeficiency syndrome	0.0025	0.00295	CcSEcCtD
Methocarbamol—Leukopenia—Ritonavir—acquired immunodeficiency syndrome	0.00249	0.00294	CcSEcCtD
Methocarbamol—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.00249	0.00294	CcSEcCtD
Methocarbamol—Confusional state—Delavirdine—acquired immunodeficiency syndrome	0.00248	0.00293	CcSEcCtD
Methocarbamol—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.00248	0.00293	CcSEcCtD
Methocarbamol—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.00246	0.00291	CcSEcCtD
Methocarbamol—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.00246	0.00291	CcSEcCtD
Methocarbamol—Insomnia—Indinavir—acquired immunodeficiency syndrome	0.00246	0.0029	CcSEcCtD
Methocarbamol—Loss of consciousness—Ritonavir—acquired immunodeficiency syndrome	0.00245	0.00289	CcSEcCtD
Methocarbamol—Rash—Didanosine—acquired immunodeficiency syndrome	0.00244	0.00289	CcSEcCtD
Methocarbamol—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.00244	0.00288	CcSEcCtD
Methocarbamol—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.00244	0.00288	CcSEcCtD
Methocarbamol—Headache—Didanosine—acquired immunodeficiency syndrome	0.00243	0.00287	CcSEcCtD
Methocarbamol—Shock—Delavirdine—acquired immunodeficiency syndrome	0.00242	0.00286	CcSEcCtD
Methocarbamol—Somnolence—Indinavir—acquired immunodeficiency syndrome	0.00242	0.00286	CcSEcCtD
Methocarbamol—Convulsion—Ritonavir—acquired immunodeficiency syndrome	0.00241	0.00285	CcSEcCtD
Methocarbamol—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.00241	0.00285	CcSEcCtD
Methocarbamol—Vertigo—Saquinavir—acquired immunodeficiency syndrome	0.00241	0.00284	CcSEcCtD
Methocarbamol—Syncope—Saquinavir—acquired immunodeficiency syndrome	0.0024	0.00284	CcSEcCtD
Methocarbamol—Leukopenia—Saquinavir—acquired immunodeficiency syndrome	0.0024	0.00283	CcSEcCtD
Methocarbamol—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.00239	0.00283	CcSEcCtD
Methocarbamol—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.00239	0.00282	CcSEcCtD
Methocarbamol—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.00238	0.00281	CcSEcCtD
Methocarbamol—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	0.00236	0.00278	CcSEcCtD
Methocarbamol—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.00234	0.00277	CcSEcCtD
Methocarbamol—Angioedema—Lamivudine—acquired immunodeficiency syndrome	0.00234	0.00276	CcSEcCtD
Methocarbamol—Pain—Indinavir—acquired immunodeficiency syndrome	0.00232	0.00275	CcSEcCtD
Methocarbamol—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.00232	0.00274	CcSEcCtD
Methocarbamol—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.00232	0.00274	CcSEcCtD
Methocarbamol—Convulsion—Saquinavir—acquired immunodeficiency syndrome	0.00232	0.00274	CcSEcCtD
Methocarbamol—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.00231	0.00273	CcSEcCtD
Methocarbamol—Nausea—Didanosine—acquired immunodeficiency syndrome	0.0023	0.00272	CcSEcCtD
Methocarbamol—Vertigo—Lamivudine—acquired immunodeficiency syndrome	0.0023	0.00271	CcSEcCtD
Methocarbamol—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.0023	0.00271	CcSEcCtD
Methocarbamol—Syncope—Lamivudine—acquired immunodeficiency syndrome	0.00229	0.00271	CcSEcCtD
Methocarbamol—Confusional state—Ritonavir—acquired immunodeficiency syndrome	0.00229	0.00271	CcSEcCtD
Methocarbamol—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	0.00229	0.0027	CcSEcCtD
Methocarbamol—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.00228	0.0027	CcSEcCtD
Methocarbamol—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.00226	0.00267	CcSEcCtD
Methocarbamol—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	0.00225	0.00266	CcSEcCtD
Methocarbamol—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.00224	0.00265	CcSEcCtD
Methocarbamol—Shock—Ritonavir—acquired immunodeficiency syndrome	0.00224	0.00264	CcSEcCtD
Methocarbamol—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.00223	0.00264	CcSEcCtD
Methocarbamol—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.00222	0.00263	CcSEcCtD
Methocarbamol—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.00222	0.00263	CcSEcCtD
Methocarbamol—Convulsion—Lamivudine—acquired immunodeficiency syndrome	0.00222	0.00262	CcSEcCtD
Methocarbamol—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.00221	0.00262	CcSEcCtD
Methocarbamol—Confusional state—Saquinavir—acquired immunodeficiency syndrome	0.00221	0.00261	CcSEcCtD
Methocarbamol—Pain—Efavirenz—acquired immunodeficiency syndrome	0.0022	0.0026	CcSEcCtD
Methocarbamol—Rash—Nevirapine—acquired immunodeficiency syndrome	0.0022	0.00259	CcSEcCtD
Methocarbamol—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.00219	0.00259	CcSEcCtD
Methocarbamol—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.00219	0.00259	CcSEcCtD
Methocarbamol—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.00218	0.00258	CcSEcCtD
Methocarbamol—Headache—Nevirapine—acquired immunodeficiency syndrome	0.00218	0.00258	CcSEcCtD
Methocarbamol—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.00216	0.00256	CcSEcCtD
Methocarbamol—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.00216	0.00255	CcSEcCtD
Methocarbamol—Shock—Saquinavir—acquired immunodeficiency syndrome	0.00215	0.00254	CcSEcCtD
Methocarbamol—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.00215	0.00254	CcSEcCtD
Methocarbamol—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.00214	0.00253	CcSEcCtD
Methocarbamol—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.00214	0.00253	CcSEcCtD
Methocarbamol—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.00213	0.00251	CcSEcCtD
Methocarbamol—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.00212	0.00251	CcSEcCtD
Methocarbamol—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.00212	0.00251	CcSEcCtD
Methocarbamol—Rash—Stavudine—acquired immunodeficiency syndrome	0.00212	0.00251	CcSEcCtD
Methocarbamol—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.00212	0.0025	CcSEcCtD
Methocarbamol—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.00212	0.0025	CcSEcCtD
Methocarbamol—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.00211	0.0025	CcSEcCtD
Methocarbamol—Headache—Stavudine—acquired immunodeficiency syndrome	0.00211	0.00249	CcSEcCtD
Methocarbamol—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.00211	0.00249	CcSEcCtD
Methocarbamol—Confusional state—Lamivudine—acquired immunodeficiency syndrome	0.0021	0.00249	CcSEcCtD
Methocarbamol—Pain—Delavirdine—acquired immunodeficiency syndrome	0.0021	0.00248	CcSEcCtD
Methocarbamol—Rash—Abacavir—acquired immunodeficiency syndrome	0.00209	0.00247	CcSEcCtD
Methocarbamol—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.00209	0.00247	CcSEcCtD
Methocarbamol—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.00209	0.00247	CcSEcCtD
Methocarbamol—Headache—Abacavir—acquired immunodeficiency syndrome	0.00208	0.00245	CcSEcCtD
Methocarbamol—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.00207	0.00244	CcSEcCtD
Methocarbamol—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.00207	0.00244	CcSEcCtD
Methocarbamol—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.00206	0.00243	CcSEcCtD
Methocarbamol—Shock—Lamivudine—acquired immunodeficiency syndrome	0.00205	0.00243	CcSEcCtD
Methocarbamol—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.00204	0.00241	CcSEcCtD
Methocarbamol—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.00204	0.00241	CcSEcCtD
Methocarbamol—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.00203	0.0024	CcSEcCtD
Methocarbamol—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.00203	0.00239	CcSEcCtD
Methocarbamol—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.00202	0.00239	CcSEcCtD
Methocarbamol—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.002	0.00237	CcSEcCtD
Methocarbamol—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.002	0.00237	CcSEcCtD
Methocarbamol—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.002	0.00236	CcSEcCtD
Methocarbamol—Nausea—Stavudine—acquired immunodeficiency syndrome	0.002	0.00236	CcSEcCtD
Methocarbamol—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.00198	0.00234	CcSEcCtD
Methocarbamol—Nausea—Abacavir—acquired immunodeficiency syndrome	0.00197	0.00233	CcSEcCtD
Methocarbamol—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.00195	0.00231	CcSEcCtD
Methocarbamol—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.00195	0.0023	CcSEcCtD
Methocarbamol—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.00194	0.0023	CcSEcCtD
Methocarbamol—Pain—Ritonavir—acquired immunodeficiency syndrome	0.00194	0.0023	CcSEcCtD
Methocarbamol—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.00194	0.0023	CcSEcCtD
Methocarbamol—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.00193	0.00228	CcSEcCtD
Methocarbamol—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.00193	0.00227	CcSEcCtD
Methocarbamol—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.00192	0.00227	CcSEcCtD
Methocarbamol—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.00189	0.00224	CcSEcCtD
Methocarbamol—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.00189	0.00223	CcSEcCtD
Methocarbamol—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.00187	0.00221	CcSEcCtD
Methocarbamol—Pain—Saquinavir—acquired immunodeficiency syndrome	0.00187	0.00221	CcSEcCtD
Methocarbamol—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.00186	0.0022	CcSEcCtD
Methocarbamol—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.00185	0.00219	CcSEcCtD
Methocarbamol—Rash—Zidovudine—acquired immunodeficiency syndrome	0.00184	0.00218	CcSEcCtD
Methocarbamol—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.00184	0.00218	CcSEcCtD
Methocarbamol—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.00184	0.00217	CcSEcCtD
Methocarbamol—Headache—Zidovudine—acquired immunodeficiency syndrome	0.00183	0.00216	CcSEcCtD
Methocarbamol—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.00182	0.00215	CcSEcCtD
Methocarbamol—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.00181	0.00214	CcSEcCtD
Methocarbamol—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.00181	0.00213	CcSEcCtD
Methocarbamol—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.0018	0.00213	CcSEcCtD
Methocarbamol—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.0018	0.00212	CcSEcCtD
Methocarbamol—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.0018	0.00212	CcSEcCtD
Methocarbamol—Pain—Lamivudine—acquired immunodeficiency syndrome	0.00178	0.00211	CcSEcCtD
Methocarbamol—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.00174	0.00205	CcSEcCtD
Methocarbamol—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.00174	0.00205	CcSEcCtD
Methocarbamol—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.00174	0.00205	CcSEcCtD
Methocarbamol—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.00173	0.00204	CcSEcCtD
Methocarbamol—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.00173	0.00204	CcSEcCtD
Methocarbamol—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.00172	0.00203	CcSEcCtD
Methocarbamol—Rash—Indinavir—acquired immunodeficiency syndrome	0.00171	0.00203	CcSEcCtD
Methocarbamol—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.00171	0.00202	CcSEcCtD
Methocarbamol—Headache—Indinavir—acquired immunodeficiency syndrome	0.0017	0.00201	CcSEcCtD
Methocarbamol—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.0017	0.00201	CcSEcCtD
Methocarbamol—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.00167	0.00198	CcSEcCtD
Methocarbamol—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.00166	0.00196	CcSEcCtD
Methocarbamol—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.00165	0.00195	CcSEcCtD
Methocarbamol—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.00163	0.00193	CcSEcCtD
Methocarbamol—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.00162	0.00192	CcSEcCtD
Methocarbamol—Rash—Efavirenz—acquired immunodeficiency syndrome	0.00162	0.00191	CcSEcCtD
Methocarbamol—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.00162	0.00191	CcSEcCtD
Methocarbamol—Nausea—Indinavir—acquired immunodeficiency syndrome	0.00161	0.00191	CcSEcCtD
Methocarbamol—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.00161	0.0019	CcSEcCtD
Methocarbamol—Headache—Efavirenz—acquired immunodeficiency syndrome	0.00161	0.0019	CcSEcCtD
Methocarbamol—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.00161	0.0019	CcSEcCtD
Methocarbamol—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.00156	0.00185	CcSEcCtD
Methocarbamol—Rash—Delavirdine—acquired immunodeficiency syndrome	0.00155	0.00183	CcSEcCtD
Methocarbamol—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.00155	0.00183	CcSEcCtD
Methocarbamol—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.00155	0.00183	CcSEcCtD
Methocarbamol—Headache—Delavirdine—acquired immunodeficiency syndrome	0.00154	0.00182	CcSEcCtD
Methocarbamol—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.00154	0.00182	CcSEcCtD
Methocarbamol—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.00153	0.0018	CcSEcCtD
Methocarbamol—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.0015	0.00178	CcSEcCtD
Methocarbamol—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.00148	0.00174	CcSEcCtD
Methocarbamol—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.00146	0.00172	CcSEcCtD
Methocarbamol—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.00145	0.00171	CcSEcCtD
Methocarbamol—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.00144	0.00171	CcSEcCtD
Methocarbamol—Rash—Ritonavir—acquired immunodeficiency syndrome	0.00143	0.00169	CcSEcCtD
Methocarbamol—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.00143	0.00169	CcSEcCtD
Methocarbamol—Headache—Ritonavir—acquired immunodeficiency syndrome	0.00142	0.00168	CcSEcCtD
Methocarbamol—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.00139	0.00164	CcSEcCtD
Methocarbamol—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.00138	0.00163	CcSEcCtD
Methocarbamol—Rash—Saquinavir—acquired immunodeficiency syndrome	0.00138	0.00163	CcSEcCtD
Methocarbamol—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.00138	0.00163	CcSEcCtD
Methocarbamol—Headache—Saquinavir—acquired immunodeficiency syndrome	0.00137	0.00162	CcSEcCtD
Methocarbamol—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.00135	0.00159	CcSEcCtD
Methocarbamol—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.00133	0.00157	CcSEcCtD
Methocarbamol—Rash—Lamivudine—acquired immunodeficiency syndrome	0.00132	0.00155	CcSEcCtD
Methocarbamol—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.00131	0.00155	CcSEcCtD
Methocarbamol—Headache—Lamivudine—acquired immunodeficiency syndrome	0.00131	0.00154	CcSEcCtD
Methocarbamol—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.0013	0.00154	CcSEcCtD
Methocarbamol—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.00124	0.00146	CcSEcCtD
